Survival Benefit of Breast Surgery for Low-Grade Ductal Carcinoma In Situ-Reference-Cited by-同舟云学术

Survival Benefit of Breast Surgery for Low-Grade Ductal Carcinoma In Situ

Published:2015-08-01 Issue:8 Volume:150 Page:739
ISSN:2168-6254
Container-title:JAMA Surgery
language:en
Short-container-title:JAMA Surg

Author:

Sagara Yasuaki¹,Mallory Melissa Anne¹,Wong Stephanie²,Aydogan Fatih³,DeSantis Stephen⁴,Barry William T.⁵,Golshan Mehra¹

Affiliation:

1. Department of Surgery, Brigham and Women’s Hospital, Boston, Massachusetts

2. Department of Surgery, McGill University Health Centre, Montreal, Québec, Canada3Harvard School of Public Health, Boston, Massachusetts

3. Department of Surgery, Brigham and Women’s Hospital, Boston, Massachusetts4Department of Breast Surgery, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey

4. Department of Breast Oncology Center, Dana-Farber Cancer Institute, Boston, Massachusetts

5. Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts

Publisher

American Medical Association (AMA)

Subject

Surgery

Cited by 168 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on the management of ductal carcinoma in situ of the breast: current approach and future perspectives;Japanese Journal of Clinical Oncology;2024-09-02

2. Disease-specific survival outcomes for patients after locoregional treatment for ductal carcinoma in situ: observational cohort study;British Journal of Surgery;2024-08-30

3. Outcomes from low-risk ductal carcinoma in situ: a systematic review and meta-analysis;Breast Cancer Research and Treatment;2024-08-24

4. Imaging Changes and Outcomes of Patients Undergoing Active Monitoring for Ductal Carcinoma In Situ: Seven-Year Follow-up Study;Academic Radiology;2024-07

5. Ultrasound deep learning radiomics and clinical machine learning models to predict low nuclear grade, ER, PR, and HER2 receptor status in pure ductal carcinoma in situ;Gland Surgery;2024-04